Company Filing History:
Years Active: 2009
Title: Klaus Olaf Börnsen: Innovator in Pharmaceutical Chemistry
Introduction
Klaus Olaf Börnsen is a notable inventor based in Staufen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on N-phenyl-2-pyrimidine-amine derivatives. His research has implications for the therapeutic treatment of warm-blooded animals, including humans.
Latest Patents
Klaus Olaf Börnsen holds a patent for N-oxides of N-phenyl-2-pyrimidine-amine derivatives. This invention relates to compounds where at least one nitrogen atom carries an oxygen atom, forming the corresponding N-oxides. The patent also covers processes for the preparation of these compounds, pharmaceutical compositions that include them, and their use in therapeutic treatments.
Career Highlights
Börnsen is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative pharmaceutical solutions that address various health challenges.
Collaborations
Throughout his career, Klaus has collaborated with esteemed colleagues such as Peter End and Gerhard Gross. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical sciences.
Conclusion
Klaus Olaf Börnsen's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the field. His work continues to impact the development of therapeutic treatments for various conditions.